Sartorius (OTCMKTS:SARTF) Shares Gap Down - What's Next?

Key Points

• Sartorius shares gapped down significantly from a previous close of $201.69 to an opening of $181.58, reflecting a 10.0% decline in value.
• The company reported earnings per share of $1.38 for the last quarter, missing analyst expectations of $1.49, while revenue exceeded expectations at $1.04 billion.
• Jefferies Financial Group upgraded Sartorius to a "strong-buy" rating, with a consensus rating from analysts indicating a strong favor for the stock.

Sartorius (OTCMKTS:SARTF - Get Free Report) gapped down before the market opened on Tuesday . The stock had previously closed at $201.69, but opened at $181.58. Sartorius shares last traded at $181.58, with a volume of 175 shares.

Analyst Ratings Changes

Separately, Jefferies Financial Group raised shares of Sartorius to a "strong-buy" rating in a report on Tuesday, August 12th. Three equities research analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, Sartorius has a consensus rating of "Strong Buy".

Sartorius Trading Down 10.0%

The company has a quick ratio of 0.88, a current ratio of 1.39 and a debt-to-equity ratio of 1.08. The firm has a market capitalization of $6.22 billion, a price-to-earnings ratio of 110.72 and a beta of 1.00. The business's 50-day simple moving average is $189.03 and its two-hundred day simple moving average is $193.19.

Sartorius (OTCMKTS:SARTF - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The company reported $1.38 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.49 by ($0.11). The firm had revenue of $1.04 billion during the quarter, compared to analysts' expectations of $977.90 million. Sartorius had a return on equity of 7.79% and a net margin of 3.00%.

About Sartorius

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.